Follow the Guard Therapeutics International AB (publ) stock price and the full insider trade history of the company, a listed equity based in Finland. Shares are quoted on the FI market, under the oversight of FIN-FSA. Operating in the Health Care sector, Guard Therapeutics International AB (publ) has logged 10 insider filings. Market capitalisation: €28.2m. The latest transaction was reported on 16 May 2025 (Purchase). Among the most active insiders: Tobias Larsson Agervald. The full history is openly available.
10
Insider Decl.
n/a
Thresholds
€31,055
8 ops.
Buy Volume
n/a
n/a
Sell Volume
35Σ signal
Buys €31,055n/a Sells
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
3,963 shares@ €1.41060.021% mcap100.0% of flowBTA (betald tecknad aktie)ISINISIN SE0024220180FI:A003N119-1
10 of 10 declarations
About Guard Therapeutics International AB (publ)
Guard Therapeutics International AB (publ) is a Swedish biopharmaceutical company focused on developing treatments for kidney diseases. It is listed on the Stockholm Stock Exchange (XSTO).